AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Medical Cannabis Payment Solutions

$0 +$0.00 (+200.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
182.51K
AVG Volume
124.11K
Trailing/Forward PE
-3/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD)
-1.5M-1M-500K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q1-5.48K
22 Q4-5.78K
22 Q3-8.68K
22 Q2-7.78K
22 Q1-11.86K
21 Q4-30K
21 Q3-1.24M
21 Q2-165K
21 Q1-169.08K
20 Q4-215.19K
Operating Income (USD)
-1.5M-1M-500K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q1-5.48K
22 Q4-5.78K
22 Q3-8.68K
22 Q2-7.78K
22 Q1-11.86K
21 Q4-30K
21 Q3-1.24M
21 Q2-164.69K
21 Q1-313.05K
20 Q4-400.46K
EBITDA (USD)
-1.5M-1M-500K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q10
22 Q4-300
22 Q3-3.2K
22 Q2-2.3K
22 Q1-6.38K
21 Q4-24.52K
21 Q3-1.24M
21 Q2-159.22K
21 Q1-163.49K
20 Q4-209.71K
Cash Flows (USD)
-200K-150K-100K-50K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q1-10.96K
22 Q4-10.96K
22 Q3-10.96K
22 Q2-10.96K
22 Q1-1.88K
21 Q4-10.96K
21 Q3-10.96K
21 Q2-159.52K
21 Q1-163.6K
20 Q4-194.36K
EPS (USD)
-0-0-0-0020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG EPS (USD) by quarter
PeriodEPS (USD)
23 Q1-0
22 Q4-0
22 Q3-0
22 Q2-0
22 Q1-0
21 Q4-0
21 Q3-0
21 Q2-0
21 Q1-0
20 Q4-0
Expenses (USD)
-500K0500K1M1.5MR&DSG&ACapex20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q10
22 Q4300
22 Q33.2K
22 Q22.3K
22 Q16.38K
21 Q424.52K
21 Q31.24M
21 Q2159.22K
21 Q1307.57K
20 Q4394.97K
Cash & Debt (USD)
0250K500K750K1MCashShort Term Debt20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q10
22 Q40
22 Q30
22 Q20
22 Q10
21 Q41.88K
21 Q31.88K
21 Q21.88K
21 Q111.4K
20 Q410
Debt ratios
-150-100-50020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Debt ratios by quarter
PeriodDebt ratios
23 Q1-147.86
22 Q4-70.4
22 Q3-23.56
22 Q2-0.67
22 Q1-0.6
21 Q4-0.54
21 Q3-0.48
21 Q2-1.53
21 Q1-2.12
20 Q4-2.77
Return on Capital
0%20%40%60%20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Return on Capital by quarter
PeriodReturn on Capital
23 Q10.23%
22 Q40.25%
22 Q30.37%
22 Q20.34%
22 Q10.51%
21 Q41.31%
21 Q354.95%
21 Q216.18%
21 Q116.83%
20 Q425.76%
Shares Outstanding
0200M400M600M800M20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Shares Outstanding by quarter
PeriodShares Outstanding
23 Q1608.38M
22 Q4608.38M
22 Q3608.38M
22 Q2608.38M
22 Q1608.38M
21 Q4608.38M
21 Q3608.38M
21 Q2608.38M
21 Q1544.09M
20 Q4544.09M
Book Value Per Share (USD)
-0-0-0-0020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q1-0
22 Q4-0
22 Q3-0
22 Q2-0
22 Q1-0
21 Q4-0
21 Q3-0
21 Q2-0
21 Q1-0
20 Q4-0
Total Assets (USD)
025K50K75K100K20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
REFG Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q132.76K
22 Q438.24K
22 Q343.72K
22 Q249.2K
22 Q154.68K
21 Q462.04K
21 Q367.52K
21 Q273K
21 Q188K
20 Q482.08K
Free Cash Flow Yield
-8000%-6000%-4000%-2000%0%med -72.05%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
REFG Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-24.02%
Sep 26-7205.07%
Aug 26-24.02%
Aug 26-24.02%
Aug 26-24.02%
Aug 26-24.02%
Jul 26-24.02%
Jul 26-24.02%
Jul 26-24.02%
Jul 26-24.02%
Jul 26-7205.07%
Jun 26-24.02%
Jun 26-24.02%
Jun 26-24.02%
Jun 26-24.02%
May 26-72.05%
May 26-7205.07%
May 26-72.05%
May 26-7205.07%
May 26-72.05%
Apr 26-72.05%
Apr 26-72.05%
Apr 26-72.05%
Apr 26-7205.07%
Mar 26-72.05%
Mar 26-72.05%
Mar 26-72.05%
Mar 26-72.05%
Feb 26-7205.07%
Feb 26-72.05%
Feb 26-72.05%
Feb 26-72.05%
Jan 26-72.05%
Jan 26-7205.07%
Jan 26-72.05%
Jan 26-72.05%
Jan 26-72.05%
Dec 25-72.05%
Dec 25-72.05%
Dec 25-72.05%
Dec 25-72.05%
Nov 25-72.05%
Nov 25-72.05%
Nov 25-72.05%
Nov 25-72.05%
Oct 25-72.05%
Oct 25-72.05%
Oct 25-72.05%
Oct 25-72.05%
Oct 25-72.05%
Sep 25-72.05%
Sep 25-72.05%
Sep 25-72.05%
Sep 25-72.05%
Aug 25-72.05%
Aug 25-72.05%
Aug 25-72.05%
Aug 25-72.05%
Aug 25-72.05%
Jul 25-72.05%
Jul 25-72.05%
Jul 25-72.05%
Jul 25-72.05%
Jun 25-72.05%
Jun 25-72.05%
Jun 25-72.05%
Jun 25-72.05%
May 25-72.05%
May 25-72.05%
May 25-72.05%
May 25-72.05%
May 25-72.05%
Apr 25-72.05%
Apr 25-72.05%
Apr 25-72.05%
Apr 25-72.05%
Mar 25-72.05%
Mar 25-72.05%
Mar 25-72.05%
Mar 25-72.05%
Feb 25-72.05%
Feb 25-72.05%
Feb 25-72.05%
Feb 25-72.05%
Jan 25-7205.07%
Jan 25-72.05%
Jan 25-72.05%
Jan 25-72.05%
Jan 25-72.05%
Dec 24-72.05%
Dec 24-72.05%
Dec 24-72.05%
Dec 24-72.05%
Nov 24-72.05%
Nov 24-72.05%
Nov 24-72.05%
Nov 24-72.05%
Nov 24-36.03%
Oct 24-72.05%
Oct 24-72.05%
Price to Book
0102030med 21.02Jul 18Aug 18Aug 18Jan 19Feb 19Mar 19Mar 19
REFG Price to Book by quarter
PeriodPrice to Book
Mar 1921.77
Mar 198.05
Mar 199.44
Mar 198.81
Mar 1910.88
Feb 1910.88
Feb 1910.7
Feb 1911.14
Feb 1911.7
Jan 1910.76
Jan 1913.84
Jan 1917.93
Jan 1914.47
Sep 1821.02
Sep 1821.32
Sep 1821.02
Aug 1821.02
Aug 1821.74
Aug 1825.58
Aug 1828.83
Aug 1823.12
Jul 1823.6
Jul 1824.62
Jul 1826.55
Jul 1827.03
Jun 1826.13
Medical Cannabis Payment Solutions
REFG
Stockpicker

Video analysis: REFG

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.